EVAX vs BURU
Comparison between Evaxion Biotech A/S (EVAX, Company) and Nuburu Inc (BURU, Company).
EVAX is from the Healthcare sector, while BURU is from the Industrials sector.
EVAX vs BURU - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
EVAX
$25M
BURU
$25M
Max Drawdown
EVAX
99.79%
Winner
BURU
99.33%
Sharpe Ratio
Winner
EVAX
0.85
BURU
-0.63
5Y Beta
EVAX
0.77
Winner
BURU
0.27
Industry
EVAX
Biotechnology
BURU
Specialty Industrial Machinery
P/E Ratio
Winner
EVAX
-0.42
BURU
-0.20
Forward P/E
EVAX
3.57
BURU
N/A
Debt to Equity
Winner
EVAX
0.00%
BURU
3656.97%
Free Cash Flow Yield
Winner
EVAX
-26.17%
BURU
-66.03%
EVAX vs BURU - Historical Returns
Returns include dividend reinvestment.
1M
EVAX
-25.43%
Winner
BURU
-13.15%
3M
EVAX
-19.31%
Winner
BURU
-13.42%
6M
Winner
EVAX
-46.96%
BURU
-83.97%
1Y
Winner
EVAX
+40.55%
BURU
-90.13%
5Y(CAGR)
EVAX
-60.95%
BURU
N/A
Max(CAGR)
Winner
EVAX
-61.28%
BURU
-84.06%
EVAX vs BURU - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | EVAX | BURU |
|---|---|---|
| 2026 | -35.24% | -83.56% |
| 2025 | +3.22% | -80.10% |
| 2024 | -88.42% | -46.34% |
| 2023 | -60.59% | N/A |
| 2022 | -61.24% | N/A |
| 2021 | -55.31% | N/A |
EVAX vs BURU Drawdown Comparison
The maximum drawdown for EVAX was -99.79%, occurring on Apr 21, 2025. This drawdown has not yet recovered.
The maximum drawdown for BURU was -99.33%, occurring on Jun 10, 2026. This drawdown has not yet recovered.
The current EVAX drawdown is -99.52%. The current BURU drawdown is -99.23%.
| Rank | EVAX | BURU |
|---|---|---|
| #1 | -99.79% Nov 4, 2021 - Apr 21, 2025 | -99.33% Aug 2, 2024 - Jun 10, 2026 |
| #2 | -47.74% Feb 8, 2021 - Nov 4, 2021 | -24.32% Jul 2, 2024 - Jul 30, 2024 |
| #3 | N/A | -3.23% Jun 26, 2024 - Jun 28, 2024 |
Correlation
Correlation between EVAX and BURU is 0.67 which considered as a moderate positive correlation - the stocks show some tendency to move together.
0.67
-101
Select Stocks to Compare
Popular: EVAX vs SPYBURU vs SPY
More Comparisons
Compare with similar stocks